AFROCENTRIC INVESTMENT CORP LIMITED - Sanlam/Afrocentric-Completion of the subscription for shares by Sanlam in a wholly owned subsidiary of Afrocentric

Sanlam/Afrocentric-Completion of the subscription for shares by Sanlam in a wholly owned subsidiary of Afrocentric

 Sanlam Limited                                  Afrocentric Investment Corporation Limited
 (Incorporated in the Republic of South          (Incorporated in the Republic of South
 Africa)                                         Africa)
 (Registration number: 1959/001562/06)           (Registration number: 1988/000570/06)
 JSE share code: SLM                             JSE Code: ACT
 NSX share code: SLA                             ISIN: ZAE000078416
 ISIN: ZAE000070660                              (“AfroCentric” or “ACT”)
 (“Sanlam”)



JOINT ANNOUNCEMENT REGARDING THE COMPLETION OF THE SUBSCRIPTION
FOR SHARES BY SANLAM IN A WHOLLY OWNED SUBSIDIARY OF AFROCENTRIC


The respective boards of ACT and Sanlam are pleased to confirm that all the suspensive
conditions relating to the Sanlam subscription, for the sum of R703 million, for a 28.7% interest
in Afrocentric Healthcare Assets Proprietary Limited (“AHA”) a wholly owned subsidiary of
Afrocentric (“the Transaction”), have been fulfilled or waived and the Transaction is now
unconditional.

The effective date of the Transaction is today, 15 December 2015.

For ease of reference shareholders are referred to the detailed joint announcement published
on the Stock Exchange News Service (“SENS”) on 30 September 2014 wherein they were
advised of the full terms of the Transaction, and the subsequent announcements relating
thereto.

Johannesburg

15 December 2015

Sponsor to ACT
Sasfin Capital (a division of Sasfin Bank Limited)



Sponsor to Sanlam
Deutsche Securities (SA) Proprietary Limited

Date: 15/12/2015 12:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.